SCHEMBL6001067

SCHEMBL6001067

O=C(O)c1ccc(NCCc2nc(-c3ccc(NCCc4ccc(C5CCCCC5)cc4)cc3)cs2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.42
NPC1 O15118 5/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
POLB P06746 2/20 0.42
MAPT P10636 2/20 0.41
MAPK1 P28482 2/20 0.41
MRE11 P49959 1/20 0.41
LMNA P02545 1/20 0.41
HRH3 Q9Y5N1 1/20 0.39
KDM4E B2RXH2 4/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
CSNK2A1 P68400 2/20 0.39
ALDH1A1 P00352 1/20 0.39
NAMPT P43490 1/20 0.38
DHODH Q02127 1/20 0.38
HDAC3 O15379 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5999739 0.95 MRE11 (0.40) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL5999085 0.92 ADRB3 (0.41) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL5999789 0.92 MEN1 (0.38) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL5999737 0.90 RAB9A (0.40) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL6001062 0.89 RAB9A (0.39) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL5999893 0.89 RAB9A (0.39) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL5999229 0.89 NPC1 (0.41) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL5999747 0.89 OPRM1 (0.41) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL6000151 0.88 GCGR (0.41) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL5999078 0.87 AVPR1B (0.42) RAB9ANPC1MEN1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 RAB9A 1393/4885NPC1 955/4885MEN1 4550/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.